MAIA – maia biotechnology, inc. (US:AMEX)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

MAIA

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/7

08:47 am

maia

MAIA Biotechnology Announces Participation by Director Stan Smith, Ph.D. in Recent Private Placement

Low Report

MAIA Biotechnology Announces Participation by Director Stan Smith, Ph.D. in Recent Private Placement

Report

11/5

09:47 am

maia

MAIA Biotechnology Announces Late-Breaking Abstract of THIO-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting [Yahoo! Finance]

Low Report

Report

11/5

09:45 am

maia

MAIA Biotechnology Announces Late-Breaking Abstract of THIO-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

Medium Report

MAIA Biotechnology Announces Late-Breaking Abstract of THIO-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

Report

10/30

11:00 am

maia

Clinical Late-Breaking Abstracts Announced for the Society for Immunotherapy of Cancer's 39th Annual Meeting

Low Report

Clinical Late-Breaking Abstracts Announced for the Society for Immunotherapy of Cancer's 39th Annual Meeting

Report

10/28

07:00 pm

maia

MAIA Biotechnology Announces $2.44 Million Private Placement

Medium Report

MAIA Biotechnology Announces $2.44 Million Private Placement

Report

10/15

08:15 am

maia

MAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer Therapeutics

Neutral Report

MAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer Therapeutics

Report

9/10

06:00 am

maia

MAIA Biotechnology Announces Positive Survival Updates in Phase 2 Study of THIO in Non-Small Cell Lung Cancer

Medium Report

MAIA Biotechnology Announces Positive Survival Updates in Phase 2 Study of THIO in Non-Small Cell Lung Cancer

Report

9/4

08:30 am

maia

MAIA Biotechnology to Present New Phase 2 Clinical Trial Data at the H.C. Wainwright 26th Annual Global Investment Conference

High Report

MAIA Biotechnology to Present New Phase 2 Clinical Trial Data at the H.C. Wainwright 26th Annual Global Investment Conference

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.